Lista de obras - Victor Musiime - Dominio Público Uruguay

A Case of Cryptococcal Lymphadenitis in an HIV-Infected Child

artículo científico publicado en 2010

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

artículo científico publicado en 2014

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial

artículo científico publicado en 2015

Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children

artículo científico publicado en 2016

Adherence to antiretroviral therapy in HIV-positive adolescents in Uganda assessed by multiple methods: a prospective cohort study

artículo científico publicado en 2012

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial

artículo científico publicado en 2013

Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children

artículo científico publicado en 2013

Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and Zimbabwe

artículo científico publicado en 2013

Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study

artículo científico publicado en 2012

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

artículo científico publicado en 2016

Brief Report: Prevalence of Latent Rheumatic Heart Disease Among HIV-Infected Children in Kampala, Uganda

artículo científico publicado en 2015

Can abacavir be used safely in children without HLA testing?

artículo científico publicado en 2015

Cardiac Dysfunction Among Ugandan HIV-infected Children on Antiretroviral Therapy.

artículo científico publicado en 2015

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial

scholarly article by Frank A Post et al published 4 March 2018 in Clinical Infectious Diseases

Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation

scientific article published on 01 April 2019

Development of a psychosocial distress measure for Ugandan adolescents living with HIV.

artículo científico publicado en 2015

Disclosure of HIV Status to Perinatally Infected Adolescents in Urban Uganda: A Qualitative Study on Timing, Process, and Outcomes

artículo científico publicado en 2015

Does the CHER trial open up new therapeutic perspectives?

artículo científico publicado en 2013

Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial

artículo científico publicado en 2018

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa

artículo científico publicado en 2017

Enteric bacterial pathogens in HIV-infected children with acute diarrhea in Mulago referral and teaching hospital, Kampala, Uganda

artículo científico publicado en 2009

Examining the relationship between psychological distress and adherence to anti-retroviral therapy among Ugandan adolescents living with HIV.

artículo científico publicado en 2016

HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda

scientific article published on January 2016

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe

artículo científico publicado en 2014

Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveys

artículo científico publicado en 2017

Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic

artículo científico publicado en 2013

Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe

artículo científico publicado en 2019

Insulin Resistance and Markers of Inflammation in HIV-infected Ugandan Children in the CHAPAS-3 Trial.

artículo científico publicado en 2017

Low Incidence of Abacavir Hypersensitivity Reaction Among African Children Initiating Antiretroviral Therapy ⬇️

artículo científico publicado el 1 de junio de 2011

Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy

artículo científico publicado en 2020

Microbial translocation does not drive immune activation in Ugandan children with HIV

article

Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure

artículo científico publicado en 2017

Need for review of prevention of mother-to-child transmission practice especially in discordant couples: a case of mother-to-child transmission of HIV during breast feeding by a mother who tested HIV negative antenatally

artículo científico publicado en 2007

Once vs twice-daily abacavir and lamivudine in African children

artículo científico publicado en 2016

Opportunities for improving the efficiency of paediatric HIV treatment programmes

artículo científico publicado en 2015

PM451 Cardiac Dysfunction Among HIV Infected Children on Combination Anti Retroviral therapy Attending Joint Clinical Research Centre, Kampala Uganda

article

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial

artículo científico publicado en 2010

Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV-1-infected Ugandan children

article

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study

artículo científico publicado en 2013

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children

artículo científico publicado en 2017

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy

artículo científico publicado en 2015

Psychological distress among Ugandan adolescents living with HIV: Examining stressors and the buffering role of general and religious coping strategies

artículo científico publicado en 2016

Psychosocial challenges and strategies for coping with HIV among adolescents in Uganda: a qualitative study

artículo científico publicado en 2015

Pubertal development in HIV-infected African children on first-line antiretroviral therapy.

artículo científico publicado en 2015

Recent advances in pharmacovigilance of antiretroviral therapy in HIV-infected and exposed children

artículo científico

Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda

artículo científico publicado en 2012

Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine

artículo científico publicado en 2009

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial ⬇️

artículo científico publicado el 7 de marzo de 2013

Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance

artículo científico publicado en 2016

Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy

artículo científico publicado en 2013

Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years

artículo científico publicado en 2015

The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children

artículo científico publicado en 2010

The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa

scientific article published on 01 March 2020

The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children

artículo científico publicado en 2014

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy

artículo científico publicado en 2016

Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation

artículo científico publicado en 2017

Unmet needs persist in pediatric HIV programs: lessons from selected case studies in Uganda

artículo científico publicado en 2017

Utilization of "prevention of mother-to-child transmission" of HIV services by adolescent and young mothers in Mulago Hospital, Uganda

article

Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children

artículo científico publicado en 2017

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial

artículo científico publicado en 2017

Lista de obras de Victor Musiime

A Case of Cryptococcal Lymphadenitis in an HIV-Infected Child

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial

Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children

Adherence to antiretroviral therapy in HIV-positive adolescents in Uganda assessed by multiple methods: a prospective cohort study

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial

Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children

Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and Zimbabwe

Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

Brief Report: Prevalence of Latent Rheumatic Heart Disease Among HIV-Infected Children in Kampala, Uganda

Can abacavir be used safely in children without HLA testing?

Cardiac Dysfunction Among Ugandan HIV-infected Children on Antiretroviral Therapy.

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial

Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation

Development of a psychosocial distress measure for Ugandan adolescents living with HIV.

Disclosure of HIV Status to Perinatally Infected Adolescents in Urban Uganda: A Qualitative Study on Timing, Process, and Outcomes

Does the CHER trial open up new therapeutic perspectives?

Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa

Enteric bacterial pathogens in HIV-infected children with acute diarrhea in Mulago referral and teaching hospital, Kampala, Uganda

Examining the relationship between psychological distress and adherence to anti-retroviral therapy among Ugandan adolescents living with HIV.

HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe

Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveys

Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic

Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe

Insulin Resistance and Markers of Inflammation in HIV-infected Ugandan Children in the CHAPAS-3 Trial.

Low Incidence of Abacavir Hypersensitivity Reaction Among African Children Initiating Antiretroviral Therapy ⬇️

Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy

Microbial translocation does not drive immune activation in Ugandan children with HIV

Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure

Need for review of prevention of mother-to-child transmission practice especially in discordant couples: a case of mother-to-child transmission of HIV during breast feeding by a mother who tested HIV negative antenatally

Once vs twice-daily abacavir and lamivudine in African children

Opportunities for improving the efficiency of paediatric HIV treatment programmes

PM451 Cardiac Dysfunction Among HIV Infected Children on Combination Anti Retroviral therapy Attending Joint Clinical Research Centre, Kampala Uganda

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial

Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV-1-infected Ugandan children

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy

Psychological distress among Ugandan adolescents living with HIV: Examining stressors and the buffering role of general and religious coping strategies

Psychosocial challenges and strategies for coping with HIV among adolescents in Uganda: a qualitative study

Pubertal development in HIV-infected African children on first-line antiretroviral therapy.

Recent advances in pharmacovigilance of antiretroviral therapy in HIV-infected and exposed children

Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda

Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial ⬇️

Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance

Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy

Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years

The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children

The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa

The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy

Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation

Unmet needs persist in pediatric HIV programs: lessons from selected case studies in Uganda

Utilization of "prevention of mother-to-child transmission" of HIV services by adolescent and young mothers in Mulago Hospital, Uganda

Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial